# Male and Transgender Reproductive System
## Infectious, immunologic, and inflammatory disorders, including microbiologic and host response to insult
### infectious disorders
#### balanitis; epididymitis; orchitis; prostatitis; sexually transmitted infections and exposure; chancroid (Haemophilus ducreyi); genital herpes; gonorrhea (Neisseria gonorrhoeae); human papillomavirus infection, genital/venereal/anal warts, condylomata acuminata; lymphogranuloma venereum (Chlamydia trachomatis); syphilis (Treponema pallidum); trichomoniasis (Trichomonas vaginalis); urethritis, chlamydial and nonchlamydial, nongonococcal
### immunologic and inflammatory disorders
#### autoimmune hypogonadism
## Neoplasms
### malignant neoplasms, penile, prostate, testicular, breast
## Metabolic and regulatory disorders, including sexual dysfunction
### erectile dysfunction, impotence; infertility, male factor; male sexual dysfunction; premature ejaculation
## Traumatic and mechanical disorders
### benign prostatic hyperplasia/hypertrophy; circumcision, including complications; epididymal cyst; hydrocele (including neonatal hydrocele); injuries, wounds, and burns to male genitalia, including blast injuries; penile laceration, penile fracture, Peyronie disease; phimosis; scrotal laceration; spermatocele; testicular rupture/avulsion/laceration; torsion of testis; urethral laceration/disruption; varicocele
## Congenital disorders
### hypospadias; Klinefelter syndrome; undescended testicle
## Adverse effects of drugs on the male reproductive system
### alcohol; androgens, testosterone; antipsychotics, antidepressants including selective serotonin reuptake inhibitors; beta-adrenergic blockers; diuretic-including thiazides; drug-induced priapism (eg, trazodone); finasteride, dutasteride; sildenafil, tadalafil, vardenafil; marijuana; nitric oxide reductase inhibitors
